AlphaYouEC
Insider selling
Ecor1 Capital, Llc sold $65M of First Tracks Biotherapeutics, Inc. (TRAX) stock
Ecor1 Capital, Llc, 10% owner of First Tracks Biotherapeutics, Inc. (TRAX), sold 4,705,575 shares of TRAX stock worth $65M, per an SEC Form 4 filed Apr 22, 2026.
It was an open-market sale.
The trade happened on Apr 20, 2026, 2 days before it was made public.
TRAX has moved +109.6% since the trade date, from $18.60 to $38.99 (Sep 21, 2026 close).
- Traded
- Apr 20, 2026
- Disclosed
- Apr 22, 2026
- Filing delay
- 2 days
- Price since
- +109.6%
- Role
- 10% owner
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.